Table 2.
Peri- and post-operative data
| Predictora | Patients without AF (n = 409) |
Patients with AF (n = 45) |
p Value |
|---|---|---|---|
| Lung cancer characteristics | |||
| Cancer location, n (%) | 0.011 | ||
| Right lung | 236 (57.7) | 17 (37.8) | |
| Left lung | 173 (42.3) | 28 (62.2) | |
| UICC Stage, n (%)b | 0.568 | ||
| Stage I | 211 (54.0) | 24 (54.5) | |
| Stage II | 86 (22.0) | 7 (15.9) | |
| Stage III/IV | 94 (24.0) | 13 (29.5) | |
| Histology, n (%) | 0.281 | ||
| Squamous cell ca | 140 (34.2) | 21 (46.7) | |
| Adenocarcinoma | 209 (51.1) | 21 (46.7) | |
| Large cell | 24 (5.9) | 1 (2.2) | |
| Other | 36 (8.8) | 2 (4.4) | |
| Perioperative data | |||
| PaO2, mmHg | 85.3 ± 30.8 | 86.9 ± 16.3 | 0.729 |
| Ventilation time, h | 3.2 ± 0.7 | 3.2 ± 0.7 | 0.540 |
| Inotropes, n (%) | 23 (5.6) | 2 (4.4) | 0.999 |
| Blood transfusions, n (%) | 36 (8.8) | 13 (28.9) | < 0.001 |
| Postoperative data | |||
| Reoperation for bleeding, n (%) | 3 (0.7) | 0 (0) | 0.999 |
| FBS, n (%) | 31 (7.1) | 13 (24.4) | < 0.001 |
| AMI, n (%) | 2 (0.5) | 2 (4.4) | 0.051 |
| CVA, n (%) | 7 (1.7) | 2 (4.4) | 0.221 |
| AKI, n (%) | 14 (3.4) | 3 (6.7) | 0.232 |
| Respiratory failure, n (%) | 3 (0.7) | 5 (11.1) | < 0.001 |
| Pneumonia, n (%) | 5 (1.2) | 2 (4.4) | 0.146 |
| Length of stay, days | 12.2 ± 5.2 | 15.3 ± 10.1 | 0.001 |
| ICU admission n (%) | 16 (3.9) | 6 (13.3) | 0.015 |
| Hospital Mortality n (%) | 4 (1.0) | 3 (6.7) | 0.024 |
a For continuous variables, mean ± SD (standard deviation); for categorical variables, number (percent)
b UICC stage [11] not available for the 19 (4.2%) patients with tumor type other than NSCLC
AKI acute kidney injury (according RIFLE criteria), AMI acute myocardial infarction, CVA cerebrovascular accident (stroke + transient ischemic attack), FBS fibrobronchoscopy, ICU intensive care unit, PaO2 partial arterial oxygen pressure, UICC Union International Contre le Cancer